Benefit of OTC Formula Against COVID-19 Is Explained by Selection Bias
Main Author: | Harri Hemilä |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-11-01
|
Series: | Journal of Evidence-Based Integrative Medicine |
Online Access: | https://doi.org/10.1177/2515690X211058417 |
Similar Items
-
Bias against Vitamin C in Mainstream Medicine: Examples from Trials of Vitamin C for Infections
by: Harri Hemilä, et al.
Published: (2022-01-01) -
Restoring ornithine transcarbamylase (OTC) activity in an OTC‐deficient mouse model using LUNAR‐OTC mRNA
by: Hailong Yu, et al.
Published: (2022-06-01) -
The effect of β-carotene on the mortality of male smokers is modified by smoking and by vitamins C and E: evidence against a uniform effect of nutrient
by: Harri Hemilä
Published: (2020-01-01) -
Commentary: The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19
by: Harri Hemilä, et al.
Published: (2021-04-01) -
Vitamin C and COVID-19
by: Harri Hemilä, et al.
Published: (2021-01-01)